Leflunomide-13C6
Leflunomide-13C6 (HWA486-13C6) is 13C labeled Leflunomide. Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic agent.
Product Specifications
Product Name Alternative
HWA486-13C6; RS-34821-13C6; SU101-13C6
UNSPSC
12352005
Target
Bacterial; Dihydroorotate Dehydrogenase; Endogenous Metabolite; Isotope-Labeled Compounds
Related Pathways
Anti-infection; Metabolic Enzyme/Protease; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C1=C(C)ON=C1)N[13C]2=[13C][13C]=[13C](C(F)(F)F)[13C]=[13C]2
Molecular Formula
C6 13C6H5F3N2O2
Molecular Weight
272.13
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Fox RI, et al. Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol. 1999 Dec;93 (3) :198-208.|[3]Xu X, et al. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem. 1995 May 26;270 (21) :12398-403.|[4]Davis JP, et al. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry. 1996 Jan 30;35 (4) :1270-3.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx08212-1mgEcoli 1 mg (E. coli)
Recombinant Shigella Flexneri thrL Protein (aa 1-21) (serotype 5b)
Sign In for Pricing
View Details 
MBS737647-01 48 Well
Goat Tumor necrosis factor soluble receptor I ELISA Kit
Sign In for Pricing
View Details MBS737647-02 96 Well
Goat Tumor necrosis factor soluble receptor I ELISA Kit
Sign In for Pricing
View Details MBS737647-03 5x 96 Well
Goat Tumor necrosis factor soluble receptor I ELISA Kit
Sign In for Pricing
View Details